HOME >> MEDICINE >> NEWS
Swedish trials suggest modest benefit for screening mammography

New data with longer follow-up from four Swedish trials published in this weeks issue of THE LANCET suggests there may be a modest benefit from screening mammography for women aged 55 years or over.

Considerable debate surrounds the issue of screening mammography and its possible benefits. A research letter by Ole Olsen and Peter Gotzsche (Lancet 2001; 358: 1340-42) concluded that there was no reliable evidence from randomised trials to support the benefit of screening mammography. Lennarth Nystrom and colleagues from the University of Umea, Sweden, present new data updating the overview of four Swedish randomised controlled trials on mammography screening up to and including 1996. The study also contains data from the trials that have not been presented before.

The trials include data for about 247,000 women, who were followed-up by record linkage to the Swedish Cancer and Cause of Death Registers. The relative risks for breast cancer death and death from all causes were calculated for women given screening mammography and those not invited for screening (the control groups in the four trials).

Average follow-up time for the trials was 15.8 years. There were 511 breast cancer deaths in 1 864 770 women-years in the groups given mammography, and 584 breast cancer deaths in 1 688 440 women-years in the control groupsresulting in a significant 21% reduction in breast cancer mortality for women given screening mammography. The reduction was greatest (33%)in the age group 6069 years at entry to the trials. There were statistically significant effects in the age groups 5559, 6064, and 6569 years, but there was only a small relative risk reduction (5%) in women aged 50-54 years. The benefit in terms of cumulative breast cancer mortality started to emerge at about 4 years after randomisation and continued to increase to about 10 years. There was no significant difference in death from all causes between screening and control groups.

Lenna
'"/>

Contact: Richard Lane
richard.lane@lancet.com
44-20-7424-4949
Lancet
14-Mar-2002


Page: 1 2

Related medicine news :

1. Promising new strategy for Swedish medical research
2. Hopkins begins human trials with donor adult stem cells to repair muscle damaged from heart attack
3. US attempting to flout ethical practice for patient trials abroad
4. New trials for counseling caregivers and patients with Alzheimers begin
5. NIAID seeks applicants to lead clinical trials units for revamped HIV/AIDS networks
6. New ITN Scholars Program provides junior faculty opportunity to develop clinical trials expertise
7. OHSU researcher says FDA could broaden access to results of clinical drug trials
8. Success of experimental herpes vaccine builds momentum for human clinical trials
9. Re-analysis of large trials shows greatest benefit of chemotherapy in ER-negative tumors
10. Establishing pediatric stroke trials
11. NIAID seeks applicants to lead revamped HIV/AIDS clinical trials networks

Post Your Comments:
(Date:11/27/2014)... Cambrionix Ltd today announced that it ranked number ... of the 50 fastest-growing technology companies in the UK. ... five years. Cambrionix Ltd grew 2989 percent during this ... region of Cambridgeshire and East and first in the sector ... is recognition of the hard work put in by our ...
(Date:11/27/2014)... PITTSBURGH, PA (PRWEB) November 27, 2014 ... suffer from an embarrassing fact of life, and she ... musty a few minutes later, I decided that there ... longer periods," she said. , Easy to use and ... maintains freshness in a woman’s private areas throughout the ...
(Date:11/27/2014)... Dotinga HealthDay Reporter , WEDNESDAY, ... pre-wired to acquire a second language, new research suggests. But ... likely gain a brain boost, the small study finds. ... said study co-author Ping Li, co-director of the Center for ... even more interesting, Li said, that "the brain networks of ...
(Date:11/27/2014)... THURSDAY, Nov. 27, 2014 (HealthDay News) -- Thanksgiving meals ... eat a gluten-free diet, an expert says. Many ... potatoes and cranberry sauce -- are gluten-free, but "when ... may need to be considered," Dr. Anca Safta, director ... Wake Forest Baptist Medical Center in North Carolina, said ...
(Date:11/27/2014)... NC (PRWEB) November 27, 2014 ... 12 years in the Charlotte area providing audits, ... examination services to businesses of varying size across ... business owners to meet all of their accounting ... certification through the QuickBooks ProAdvisor Program. When asking ...
Breaking Medicine News(10 mins):Health News:Cambrionix Ltd Ranks Top 10 in the Deloitte UK Technology Fast 50 2Health News:Cambrionix Ltd Ranks Top 10 in the Deloitte UK Technology Fast 50 3Health News:Cambrionix Ltd Ranks Top 10 in the Deloitte UK Technology Fast 50 4Health News:Some People May Be Pre-Wired to Be Bilingual 2Health News:Some People May Be Pre-Wired to Be Bilingual 3Health News:Expert Shares Gluten-Free Thanksgiving Tips 2Health News:Jeffrey Carlini becomes Intuit Proadvisor and receives QuickBooks certification 2
(Date:11/26/2014)... Zynerba Pharmaceuticals , Inc., a specialty ... synthetic cannabinoid treatments, today announced that the company will ... 2014. The conference will be held December 2 to ... New York . Zynerba,s Chairman and CEO, ... Tuesday, December 2. To listen to a ...
(Date:11/26/2014)... JOSE, Calif. , Nov. 26, 2014 /PRNewswire/ ... technologies to produce novel therapies for infectious diseases, ... , M.D., an internationally recognized key opinion leader ... the Company,s scientific advisory board. Founder ... Ph.D., stated, "We believe Dr. Opal,s extensive experience ...
(Date:11/26/2014)... NEW YORK and ... the leading distributor of market intelligence, MarketResearch.com is pleased ... by IQ4I Research and Consultancy focusing on the active ... about IQ4I Research visit: http://www.marketresearch.com/land/publisher.asp?vendorid=4023&progid=86891 . ... Ingredients Global Market – Forecast to 2020 ...
Breaking Medicine Technology:Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014 2Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 2Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 3MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 2MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 3
Cached News: